Quick Answer
Vaxart, Inc. reported Operating Income of $18.07 million for fiscal year 2025.
Vaxart, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $18.07M | +127.3% |
| 2024 | -$66.29M | +20.5% |
| 2023 | -$83.35M | +27.3% |
| 2022 | -$114.59M | -57.5% |
| 2021 | -$72.75M | -141.1% |
| 2020 | -$30.17M | -91.1% |
| 2019 | -$15.79M | +27.4% |
| 2018 | -$21.76M | -117.2% |
| 2017 | -$10.02M | +63.6% |
| 2017 | -$27.50M | -9.1% |
| 2016 | -$25.20M | -29.2% |
| 2015 | -$19.50M | -69.6% |
| 2014 | -$11.50M | +48.0% |
| 2013 | -$22.10M | +3.5% |
| 2012 | -$22.90M | -134.6% |
| 2011 | -$9.76M | +68.0% |
| 2011 | -$30.50M | -2445.9% |
| 2010 | -$1.20M | +93.3% |
| 2009 | -$17.98M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.81M | +46.0% | +46.5% |
| June 30, 2025 | -$14.60M | +10.2% | +2.2% |
| March 31, 2025 | -$14.94M | +38.0% | -3.2% |
| September 30, 2024 | -$14.47M | +18.8% | +11.0% |
| June 30, 2024 | -$16.26M | +29.5% | +32.5% |
| March 31, 2024 | -$24.07M | +5.9% | -35.1% |
| September 30, 2023 | -$17.82M | +39.4% | +22.7% |
| June 30, 2023 | -$23.05M | +21.2% | +9.9% |
- Vaxart, Inc. showed an increase of +127.3% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, Vaxart, Inc.’s operating income has grown by 200.5% (from -$17.98 million to $18.07 million).
- The most recent figure is from Vaxart, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: